Patents by Inventor Hongjian Wang
Hongjian Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12265759Abstract: An image construction method and system for a heating area is provided. The method includes: obtaining an initial image according to a heating structure diagram and a building structure diagram of the heating area; segmenting the initial image according to heating attribute of the heating area to obtain a plurality of segmentation sub-graphs; performing first collection on a surface temperature of a heating pipeline according to pre-deployed surface devices corresponding to the segmentation sub-graphs, and setting first heating labels corresponding to the segmentation sub-graphs, and meanwhile, performing second collection on a regional temperature of a sub-area of the heating pipeline being located according to a pre-deployed monitoring device corresponding to the segmentation sub-graphs, and setting second heating labels; performing position and temperature analysis on a label setting result of each of the segmentation sub-graphs to obtain a heating image of the heating area.Type: GrantFiled: June 27, 2024Date of Patent: April 1, 2025Assignee: HUANENG (TIANJIN) ENERGY SALES CO., LTD.Inventors: Xuliang Li, Zexuan Yu, Xueqiang Han, Guojun Wang, Di Wu, Shunyong Shi, Zhenxing Yuan, Hongjian Zuo, Liangge Yu, Sheng Ding, Yi Zheng, Ziyu Gong, Rui Wang, Weizheng Yang
-
SCANNING CONTROL METHOD AND APPARATUS FOR ULTRASOUND SCANNING SYSTEM, AND ULTRASOUND SCANNING SYSTEM
Publication number: 20250099083Abstract: A scanning control method and apparatus for an ultrasound scanning system, and an ultrasound scanning system including: acquiring an ultrasound scanning-related document, comprising an ultrasound scanning guidance for at least one tissue to be scanned; processing the ultrasound scanning-related document using a natural language processing (NLP) model, comprising processing the ultrasound scanning guidance; and generating an ultrasound scanning protocol for the at least one tissue to be scanned on the basis of the processing the ultrasound scanning guidance, and configuring and displaying the ultrasound scanning protocol in the ultrasound scanning system.Type: ApplicationFiled: September 18, 2024Publication date: March 27, 2025Inventors: Hongjian Jiang, Siying Wang -
Patent number: 12235972Abstract: The disclosure provides a security analysis method and system based on protocol state, which relates to the technical field of protocol security protection. The method includes the following: a node traversal table is built, the node traversal table is scanned and analyzed according to the protocol trigger sequence rule, a first security evaluation factor of a protocol stack is determined, and a second security evaluation factor of each protocol is determined based on protocol normal application rule, and the trustworthiness degree of the second security factor is determined based on the first security factor, and the second security factor is revised based on the trustworthiness degree, and the security state of the protocol is determined according to the revised second security factor, thus the analysis of the protocol state is realized, and the security of the protocol can be accurately determined.Type: GrantFiled: July 9, 2024Date of Patent: February 25, 2025Assignee: HUANENG INFORMATION TECHNOLOGY CO., LTD.Inventors: Ziqiang Wen, Hongjian Qi, Shuo Han, Chenghua Qu, Yufei Wang, Lei Xu, Zhongying Pan, Sheng Ye, Shouhui Xin, Wei Li, Yujie Liu, Qiang Zhang, Chengfeng Song, Hongwei Zhang, Yanfei Xu, Xushuai Qin, Xunan Deng
-
Patent number: 12230019Abstract: The present invention discloses a decoupling divide-and-conquer facial nerve segmentation method and device. As for the characteristics of a small facial nerve structure and a low contrast, a facial nerve segmentation model including a feature extraction module, a rough segmentation module, and a fine segmentation module is constructed. The feature extraction module is configured to extract a low-level feature and a plurality of different- and high-level features. The rough segmentation module is configured to globally search the different- and high-level features for facial-nerve features and fuse them. The fine segmentation module is configured to decouple a fused feature to obtain a central body feature. After the central body feature is combined with the low-level feature to obtain an edge-detail feature, a space attention mechanism is used to extract attention features from the central body feature and the edge-detail feature, to obtain a facial nerve segmentation image.Type: GrantFiled: February 28, 2022Date of Patent: February 18, 2025Assignee: ZHEJIANG UNIVERSITYInventors: Jing Wang, Bo Dong, Hongjian He, Xiujun Cai
-
Publication number: 20250045417Abstract: The disclosure provides a security analysis method and system based on protocol state, which relates to the technical field of protocol security protection. The method includes the following: a node traversal table is built, the node traversal table is scanned and analyzed according to the protocol trigger sequence rule, a first security evaluation factor of a protocol stack is determined, and a second security evaluation factor of each protocol is determined based on protocol normal application rule, and the trustworthiness degree of the second security factor is determined based on the first security factor, and the second security factor is revised based on the trustworthiness degree, and the security state of the protocol is determined according to the revised second security factor, thus the analysis of the protocol state is realized, and the security of the protocol can be accurately determined.Type: ApplicationFiled: July 9, 2024Publication date: February 6, 2025Applicant: HUANENG INFORMATION TECHNOLOGY CO., LTD.Inventors: Ziqiang WEN, Hongjian QI, Shuo HAN, Chenghua QU, Yufei WANG, Lei XU, Zhongying PAN, Sheng YE, Shouhui XIN, Wei LI, Yujie LIU, Qiang ZHANG, Chengfeng SONG, Hongwei ZHANG, Yanfei XU, Xushuai QIN, Xunan DENG
-
Patent number: 12203365Abstract: A method for evaluating rock drillability by a nano-indentation test on a rock cutting includes: conducting a nano-indentation test on a rock cutting sample, acquiring a displacement-load curve of an indenter, and calculating a micro-hardness under the nano-indentation test; calculating mineral composition of the rock cutting sample based on a statistical distribution characteristic of the micro-hardness, and transforming the micro-hardness under the nano-indentation test on the rock cutting sample into a macro-hardness; and calculating a rock drillability grade characterized by the micro-hardness under the nano-indentation test on the rock cutting sample based on a correlation between the macro-hardness of the rock cutting sample and the rock drillability grade. In the context of few downhole rock samples and high cost, the method overcomes the limitation of sample size and shape on conventional testing and solves the difficult problem of mechanical parameter testing of deep rocks.Type: GrantFiled: August 9, 2022Date of Patent: January 21, 2025Assignee: CHINA UNIVERSITY OF PETROLEUM (EAST CHINA)Inventors: Zizhen Wang, Xianbo Lei, Weidong Zhou, Chengwen Wang, Ruihe Wang, Xian Shi, Luopeng Li, Hongjian Ni, Rui Zhang
-
Patent number: 12187710Abstract: Provided is a salt of an Syk inhibitor and a crystalline form thereof, and more specifically, provided are 5-fluoro-1-methyl-3-((5-(4-(oxetan-3-yl)piperazine-1)-yl)pyridin-2-yl)amino)-6-(1H-pyrazol-3-yl)quinoline-2(1H)-ketamine hydrochloride, a crystalline form thereof, a preparation method therefor, a pharmaceutical composition thereof and a use thereof. The hydrochloride of the compound represented by formula I and the crystalline form thereof have good salt-forming properties, high stability and low hygroscopicity, have advantages in terms of physical properties, safety and metabolic stability, and have value in prepared medicines.Type: GrantFiled: December 13, 2019Date of Patent: January 7, 2025Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.Inventors: Wenyuan Qian, Hongjian Wang, Ming Zhang, Fei Liu, Lei Xing, Zhongyuan Hu, Yahui Guo, Yanlong Liu, Huihui Zhang
-
Publication number: 20240132503Abstract: Provided are a salt form and a crystal form of a pyrazole substituted imidazo[1,2-a]quinoxaline derivative, and a preparation method therefor. Specifically disclosed are a salt form and a crystal form of a compound of formula (I), and a preparation method therefor and the use thereof in the preparation of drugs related to dual inhibitors of spleen tyrosine kinase (Syk) and vascular endothelial growth factor 2 (VEGFR2).Type: ApplicationFiled: January 12, 2022Publication date: April 25, 2024Inventors: Wenyuan QIAN, Hongjian WANG, Liang TAN, Shuhui CHEN
-
Patent number: 11958779Abstract: The MnZn ferrite material includes principal components and auxiliary components, where the principal components include: 52.5 mol % to 53.8 mol % of Fe2O3, 8.8 mol % to 12 mol % of ZnO, and the balance of MnO; the auxiliary components include: 0.35 wt % to 0.5 wt % of Co2O3, 0.03 wt % to 0.08 wt % of CaSiO3, 0.01 wt % to 0.04 wt % of Nb2O5, and 0.05 wt % to 0.12 wt % of TiO2 and RE elemental components; the RE elemental components include one or more from the group consisting of 0 wt % to 0.04 wt % of Gd2O3, 0 wt % to 0.02 wt % of Ho2O3, and 0 wt % to 0.03 wt % of Ce2O3; the auxiliary components are all represented by a mass percentage relative to a total mass of the Fe2O3, the MnO, and the ZnO.Type: GrantFiled: September 24, 2021Date of Patent: April 16, 2024Assignee: TDG HOLDING CO., LTDInventors: Hongjian Wang, Bingbing Xing, Yanfeng Huang, Qiangyuan Zhang, Zhixin Zhang
-
Publication number: 20230219960Abstract: A class of spleen tyrosine kinase (Syk) and vascular endothelial growth factor 2 (VEGFR2) dual inhibitors, and specifically disclosed are a compound represented by formula (I), a pharmaceutically acceptable salt thereof, and an application thereof in the preparation of a Syk and VEGFR2 dual inhibitor related drug.Type: ApplicationFiled: February 23, 2021Publication date: July 13, 2023Inventors: Wenyuan Qian, Hongjian Wang, Liang Tan, Shuhui Chen
-
Publication number: 20230191272Abstract: An inflatable model with lighting effects includes a light-transmissive inflatable body, an air supply component for inflating the interior of the light-transmissive inflatable body, and a main light source which emits light from the interior of the light-transmissive inflatable body. The light-transmissive inflatable body is divided into a plurality of decoration areas. Each decoration area is provided with at least one effect light source. According to the present invention, various lighting effect combinations on the inflatable model can be achieved, thus enriching the exhibition effect of the inflatable model. Therefore, the inflatable model in the present invention can attract attention of people more easily and is more suitable for activity meeting places with diversified lighting effect requirements such as Halloween, Christmas, and the like.Type: ApplicationFiled: January 31, 2022Publication date: June 22, 2023Inventor: Hongjian WANG
-
Publication number: 20230128137Abstract: A benzo five-membered cyclic compound represented by formula (I) or a pharmaceutically acceptable salt thereof has a significant effect in inhibiting the activity of anti-apoptotic Bcl-2 protein.Type: ApplicationFiled: March 8, 2021Publication date: April 27, 2023Inventors: Hongjian WANG, Wenyuan QIAN, Ming ZHANG, Jian LI, Shuhui CHEN
-
Patent number: 11468570Abstract: The present application relates to a method for acquiring maximum principal strain or a maximum principal stress status of a vessel wall.Type: GrantFiled: September 10, 2020Date of Patent: October 11, 2022Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventors: Hongjian Wang, Jieyan Ma, Yuan Ren
-
Publication number: 20220180351Abstract: This application provides a communications system (100) for automatically selecting an NFC emulation card, which includes an NFC card reader (102) and an electronic device (101). The NFC card reader (102) sends third query information which includes first identification information and a service type of an emulation card. The electronic device (101) determines whether a first emulation card exists. When determining that the first emulation card exists, the electronic device (101) determines whether a second emulation card exists. When determining that the second emulation card exists, the electronic device (101) sends fourth response information which carries second identification information. The NFC card reader (102) sends card selection instruction information. The electronic device (101) receives the card selection instruction information, and sends card selection response information.Type: ApplicationFiled: March 6, 2020Publication date: June 9, 2022Inventors: Yun ZHOU, Yongwei WANG, Xiang LI, Hongjian WANG
-
Publication number: 20220017498Abstract: Provided is a salt of an Syk inhibitor and a crystalline form thereof, and more specifically, provided are 5-fluoro-1-methyl-3-((5-(4-(oxetan-3-yl)piperazine-1)-yl)pyridin-2-yl)amino)-6-(1H-pyrazol-3-yl)quinoline-2(1H)-ketamine hydrochloride, a crystalline form thereof, a preparation method therefor, a pharmaceutical composition thereof and a use thereof. The hydrochloride of the compound represented by formula I and the crystalline form thereof have good salt-forming properties, high stability and low hygroscopicity, have advantages in terms of physical properties, safety and metabolic stability, and have value in prepared medicines.Type: ApplicationFiled: December 13, 2019Publication date: January 20, 2022Inventors: Wenyuan QIAN, Hongjian WANG, Ming ZHANG, Fei LIU, Lei XING, Zhongyuan HU, Yahui GUO, Yanlong LIU, Huihui ZHANG
-
Publication number: 20220009837Abstract: The MnZn ferrite material includes principal components and auxiliary components, where the principal components include: 52.5 mol % to 53.8 mol % of Fe2O3, 8.8 mol % to 12 mol % of ZnO, and the balance of MnO; the auxiliary components include: 0.35 wt % to 0.5 wt % of Co2O3, 0.03 wt % to 0.08 wt % of CaSiO3, 0.01 wt % to 0.04 wt % of Nb2O5, and 0.05 wt % to 0.12 wt % of TiO2 and RE elemental components; the RE elemental components include one or more from the group consisting of 0 wt % to 0.04 wt % of Gd2O3, 0 wt % to 0.02 wt % of HO2O3, and 0 wt % to 0.03 wt % of Ce2O3; the auxiliary components are all represented by a mass percentage relative to a total mass of the Fe2O3, the MnO, and the ZnO.Type: ApplicationFiled: September 24, 2021Publication date: January 13, 2022Applicant: TDG HOLDING CO., LTDInventors: Hongjian WANG, Bingbing XING, Yanfeng HUANG, Qiangyuan ZHANG, Zhixin ZHANG
-
Patent number: 11091460Abstract: Provided are a Syk inhibitor and a use method therefor, and in particular, disclosed are quinolinone represented by formula (I) or quinazoline derivatives or pharmaceutically acceptable salts thereof, a preparation method, a pharmaceutical composition, and uses in preparing a medicament for treatment of Syk receptor related diseases.Type: GrantFiled: June 14, 2018Date of Patent: August 17, 2021Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Inventors: Shilan Liu, Guibai Liang, Hongjian Wang, Ming Zhang, Shuhui Chen
-
Patent number: D1014320Type: GrantFiled: January 25, 2022Date of Patent: February 13, 2024Inventor: Hongjian Wang
-
Patent number: D1024837Type: GrantFiled: January 21, 2022Date of Patent: April 30, 2024Inventor: Hongjian Wang
-
Patent number: D1056048Type: GrantFiled: August 29, 2022Date of Patent: December 31, 2024Assignee: SHENZHEN BAIYI TECHNOLOGY CO., LTD.Inventor: Hongjian Wang